Genotype and phenotype correlations in 441 patients with epidermolysis bullosa from China.
Chen F, Wei R, Deng D, Zhang X, Cao Y, Pan C, Wang Y, Cao Q, Wang J, Zeng M, Huang L, Gu Y, Yao Z, Li M.
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):411-419. doi: 10.1111/jdv.18692. Epub 2022 Nov 5.
Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa.
Woodley DT, Cogan J, Mosallaei D, Yim K, Chen M.
J Dermatol Sci. 2021 Nov;104(2):104-111. doi: 10.1016/j.jdermsci.2021.09.006. Epub 2021 Sep 23.
Transcriptomic profiling of recessive dystrophic epidermolysis bullosa wounded skin highlights drug repurposing opportunities to improve wound healing.
Onoufriadis A, Proudfoot LE, Ainali C, Torre D, Papanikolaou M, Rayinda T, Rashidghamat E, Danarti R, Mellerio JE, Ma'ayan A, McGrath JA.
Exp Dermatol. 2022 Mar;31(3):420-426. doi: 10.1111/exd.14481. Epub 2021 Nov 2.
Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosa.
Levian B, Hou Y, Tang X, Bainvoll L, Zheng K, Badarinarayana V, Aghamohammadzadeh S, Chen M.
Mol Ther Nucleic Acids. 2024 Sep 10;35(4):102334. doi: 10.1016/j.omtn.2024.102334. eCollection 2024 Dec 10.
Dystrophic forms of epidermolysis bullosa.
Uitto J, Christiano AM.
Semin Dermatol. 1993 Sep;12(3):191-201.
Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa.
Woodley DT, Keene DR, Atha T, Huang Y, Lipman K, Li W, Chen M.
Nat Med. 2004 Jul;10(7):693-5. doi: 10.1038/nm1063. Epub 2004 Jun 13.
Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
Twaroski K, Eide C, Riddle MJ, Xia L, Lees CJ, Chen W, Mathews W, Keene DR, McGrath JA, Tolar J.
Br J Dermatol. 2019 Dec;181(6):1247-1253. doi: 10.1111/bjd.17943. Epub 2019 Jul 8.
Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa.
Kiritsi D, Garcia M, Brander R, Has C, Meijer R, Jose Escámez M, Kohlhase J, van den Akker PC, Scheffer H, Jonkman MF, Del Rio M, Bruckner-Tuderman L, Pasmooij AMG.
J Invest Dermatol. 2014 Aug;134(8):2097-2104. doi: 10.1038/jid.2014.118. Epub 2014 Feb 27.
The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa.
Chen M, Costa FK, Lindvay CR, Han YP, Woodley DT.
J Biol Chem. 2002 Jan 18;277(3):2118-24. doi: 10.1074/jbc.M108779200. Epub 2001 Nov 6.
Development and characterization of a recombinant truncated type VII collagen "minigene". Implication for gene therapy of dystrophic epidermolysis bullosa.
Chen M, O'Toole EA, Muellenhoff M, Medina E, Kasahara N, Woodley DT.
J Biol Chem. 2000 Aug 11;275(32):24429-35. doi: 10.1074/jbc.M003440200.
